<scp>ASCPT</scp> News

Food and Drug Administration, this half-day, online program, which will run from 10:00 am to 2:00 pm ET, will provide a comprehensive overview of the current and future landscape of cell and gene therapy, including the technology current applications, challenges, and prospects.Designed to be a fun and engaging offering held on ASCPT's Zoom platform, the agenda will offer a mix keynote speakers, perspectives, case studies, panel discussions, and shared learnings.Learning objectives are as follows:1. Explore current challenges and future opportunities in the field of cell and gene therapies from diverse perspectives, including those of patients, healthcare professionals, industry stakeholders, and regulatory agencies.2. Engage in discussions on how to harness the potential of clinical pharmacology and translational science to streamline and optimize the development of cell and gene therapies.3. Gain a comprehensive understanding of gene therapies and their unique pharmacological characteristics.